At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:27 ET
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026, representing 10.7% of shares outstanding. This is an increase from the prior filing (6,318,525 shares vs. 6,318,525 shares at July 31, 2026), the stake is unchanged. Fidelity remains a passive holder above the 5% threshold.
- FMR LLC (Fidelity) reported beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026.
- The stake represents 10.7% of shares outstanding.
- This is an amendment to Schedule 13G, confirming passive investment intent.
- The stake is unchanged from the prior filing (6,318,525 shares as of July 31, 2026).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access